Vapotherm, Inc. Announces CE Mark Approval for Flowrest(R) Homecare Device

STEVENSVILLE, Maryland, January 6, 2011 - Vapotherm, the global leader in High Flow Therapy products, announced
receiving CE marking for Flowrest(R), a device designed for homecare and
other low acuity environments.

The Flowrest(R) device delivers warmed humidified high-flow breathing
gases for treating spontaneously breathing patients via nasal cannula.
Flowrest(R) is designed for ease of use in the home and includes an
integrated blower and patent-pending humidification and breathing circuit
technology.

"We are excited to expand our product portfolio and greet the pent-up
demand for a high flow therapy device that is comfortable, cost-effective and
easy to use specifically for patients in the home and other low acuity
environments," said Nick Macmillan, Home Care Segment Manager.

Vapotherm, Inc. is a privately held manufacturer of respiratory care
devices for hospitals and home care use based in Stevensville, Maryland. The
Company is dedicated to the development of innovative, noninvasive
technologies for respiratory therapy, especially for the treatment of chronic
lung and acute breathing disorders. For more information, visit
www.vtherm.com.

    Contact: Kevin Thibodeau, EVP Sales and Marketing
    Vapotherm, Inc.
    198 Log Canoe Circle
    Stevensville, MD 21666
    Phone +1-410-604-3977
    Fax +1-410-604-0707

Kevin Thibodeau of Vapotherm, Inc., +1-410-604-3977